Go Pro
NYSE:ARDT

Ardent Health (ARDT) Stock Price, News & Analysis

Ardent Health logo
$11.23 +0.24 (+2.17%)
Closing price 03:58 PM Eastern
Extended Trading
$11.25 +0.02 (+0.19%)
As of 06:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Ardent Health Stock (NYSE:ARDT)

Advanced

Key Stats

Today's Range
$10.95
$11.30
50-Day Range
$8.92
$11.60
52-Week Range
$7.71
$15.48
Volume
420,271 shs
Average Volume
439,020 shs
Market Capitalization
$1.58 billion
P/E Ratio
20.42
Dividend Yield
N/A
Price Target
$13.05
Consensus Rating
Hold

Company Overview

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities. Its specialty services include oncology, women’s health, orthopedics, cardiology and neurosciences, supported by comprehensive diagnostic imaging and laboratory capabilities. The company emphasizes coordinated clinical pathways and digital health tools to improve patient access, quality of care and operational efficiency.

Ardent’s growth strategy centers on strategic partnerships and targeted acquisitions that expand its geographic footprint and service offerings. With facilities located in multiple states—including Texas, Missouri, Virginia and others—the company serves diverse communities ranging from urban centers to suburban and rural regions. Ahead of its public debut in August 2023, Ardent built a reputation for integrating acquired assets into a unified care network.

Headquartered in Nashville, Tennessee, Ardent Health is led by President and Chief Executive Officer Rusty Frantz, who brings extensive experience in healthcare operations and strategic development. Under his leadership, the company continues to pursue value-based care initiatives, invest in clinical innovation and expand its footprint to deliver high-quality, affordable healthcare solutions.

AI Generated. May Contain Errors.

Ardent Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
95th Percentile Overall Score

ARDT MarketRank™: 

Ardent Health scored higher than 95% of companies evaluated by MarketBeat, and ranked 23rd out of 917 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Ardent Health has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on no strong buy ratings, 7 buy ratings, 4 hold ratings, and 3 sell ratings.

  • Upside Potential

    Ardent Health has a consensus price target of $13.05, representing about 16.2% upside from its current price of $11.23.

  • Amount of Analyst Coverage

    Ardent Health has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Ardent Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Ardent Health are expected to grow by 25.26% in the coming year, from $0.95 to $1.19 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ardent Health is 20.42, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.61.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ardent Health is 20.42, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 271.38.

  • Price to Earnings Growth Ratio

    Ardent Health has a PEG Ratio of 3.15. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Ardent Health has a P/B Ratio of 0.95. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Ardent Health's valuation and earnings.
  • Percentage of Shares Shorted

    3.07% of the float of Ardent Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Ardent Health has a short interest ratio ("days to cover") of 7.98.
  • Change versus previous month

    Short interest in Ardent Health has recently decreased by 6.31%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Ardent Health does not currently pay a dividend.

  • Dividend Growth

    Ardent Health does not have a long track record of dividend growth.

  • News Sentiment

    Ardent Health has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Ardent Health this week, compared to 9 articles on an average week.
  • Search Interest

    4 people have searched for ARDT on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Ardent Health to their MarketBeat watchlist in the last 30 days.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $88,100.00 in company stock, which represents 0.0056% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Ardent Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $88,100.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    1.90% of the stock of Ardent Health is held by insiders.

  • Percentage Held by Institutions

    Ardent Health has minimal institutional ownership at this time.

  • Read more about Ardent Health's insider trading history.
Receive ARDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ardent Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ARDT Stock News Headlines

Ardent Health Partners, Inc. (ARDT) Gets a Buy from Guggenheim
Ardent Health (ARDT) Q2 2026 Earnings Call Transcript
The dollar reset no one told you about
Porter Stansberry says a dollar reset is underway - one that has happened only once before in America's 250-year history, back in 1974 with a secret Saudi deal that reshaped an entire generation's wealth. Today, a landmark treaty called Pax Silica - signed by 13 nations in December 2025 and barely covered in the press - is at the center of what Fortune calls 'the biggest change to the world's relationship with the dollar' in a generation. The stocks to buy, the assets to avoid, and the moves to consider are outlined in Stansberry's new briefing.tc pixel
See More Headlines

ARDT Stock Analysis - Frequently Asked Questions

Ardent Health's stock was trading at $8.81 at the beginning of the year. Since then, ARDT stock has increased by 27.5% and is now trading at $11.2290.

Ardent Health, Inc. (NYSE:ARDT) released its quarterly earnings data on Tuesday, August, 4th. The company reported $0.12 EPS for the quarter, missing the consensus estimate of $0.18 by $0.06. The firm earned $1.62 billion during the quarter, compared to analyst estimates of $1.59 billion. Ardent Health had a trailing twelve-month return on equity of 10.35% and a net margin of 1.22%.
Read the conference call transcript
.

Ardent Health (ARDT) raised $252 million in an initial public offering on Thursday, July 18th 2024. The company issued 12,000,000 shares at $20.00-$22.00 per share.

Ardent Health's top institutional investors include BlackRock Inc. (1.52%), Algert Global LLC (0.42%), Empowered Funds LLC (0.39%) and Bank of America Corp DE (0.28%).
View institutional ownership trends
.

Shares of ARDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ardent Health investors own include Broadcom (AVGO), 4D Molecular Therapeutics (FDMT), Mirum Pharmaceuticals (MIRM), Micron Technology (MU), Uber Technologies (UBER), Advanced Micro Devices (AMD) and ASML (ASML).

Company Calendar

Last Earnings
8/04/2026
Today
8/24/2026
Next Earnings (Estimated)
11/11/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Facilities
Current Symbol
NYSE:ARDT
Previous Symbol
NYSE:ARDT
CIK
1756655
Fax
N/A
Employees
25,200
Year Founded
2001

Price Target and Rating

High Price Target
$17.00
Low Price Target
$10.00
Potential Upside/Downside
+16.2%
Consensus Rating
Hold
Rating Score (0-4)
2.29
Research Coverage
14 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.55
Trailing P/E Ratio
20.42
Forward P/E Ratio
11.82
P/E Growth
3.15
Net Income
$135.81 million
Net Margins
1.22%
Pretax Margin
3.25%
Return on Equity
10.35%
Return on Assets
3.36%

Debt

Debt-to-Equity Ratio
0.61
Current Ratio
2.10
Quick Ratio
1.99

Sales & Book Value

Annual Sales
$6.32 billion
Price / Sales
0.25
Cash Flow
$2.81 per share
Price / Cash Flow
4.00
Book Value
$11.78 per share
Price / Book
0.95

Miscellaneous

Outstanding Shares
141,050,000
Free Float
138,366,000
Market Cap
$1.58 billion
Optionable
Optionable
Beta
0.70

Social Links

10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NYSE:ARDT) was last updated on 8/24/2026 by MarketBeat.com Staff.
From Our Partners